We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

53 hedge funds and large institutions have $24.5M invested in Redhill Biopharma in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $4.3M | Put options by funds: $1.84M

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

10% more funds holding

Funds holding: 48 → 53 (+5)

0% less ownership

Funds ownership: 0% → 0% (-0%)

50% less capital invested

Capital invested by funds: $49.1M → $24.5M (-$24.6M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
15
Reduced
11
Closed
9
Calls
$4.3M
Puts
$1.84M
Net Calls
+$2.45M
Net Calls Change
+$415K

Top Buyers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$522K
2
Group One Trading
Group One Trading
Illinois
+$461K
3
GS
Gagnon Securities
New York
+$332K
4
JP Morgan Chase
JP Morgan Chase
New York
+$298K
5
Citadel Advisors
Citadel Advisors
Florida
+$271K

Top Sellers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
-$5.21M
2
DCM
DAFNA Capital Management
California
-$3.14M
3
SM
Sabby Management
Florida
-$2.34M
4
II
Ibex Investors
Colorado
-$1.74M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
51
Penserra Capital Management
California
$4K – – –
Belvedere Trading
52
Belvedere Trading
Illinois
$4K +$6.78K +1 New
US Bancorp
53
US Bancorp
Minnesota
$3K +$6.78K +1 New
S
54
SignatureFD
Georgia
$2K -$6.78K -1 Closed
Koshinski Asset Management
55
Koshinski Asset Management
Illinois
$1.58K – – –
IA
56
IFP Advisors
Florida
$1K – – –
RE
57
RBC Europe
United Kingdom
$183 – – –
DCM
58
DAFNA Capital Management
California
– -$3.14M -456 Closed
SM
59
Sabby Management
Florida
– -$2.34M -340 Closed
ACM
60
ACT Capital Management
Pennsylvania
– -$964K -140 Closed
SFS
61
Sowell Financial Services
Arkansas
– -$638K -93 Closed
JG
62
Jefferies Group
New York
– -$275K -40 Closed
Renaissance Technologies
63
Renaissance Technologies
New York
– -$137K -20 Closed
JF
64
Jump Financial
Illinois
– -$101K -15 Closed
QCG
65
Quadrant Capital Group
Ohio
– -$13K -2 Closed
CP
66
Corbenic Partners
Pennsylvania
– -$1K – –
SWM
67
Spire Wealth Management
Virginia
– -$1K – –
1 2
3

RDHL Hedge Fund Activity: Q3 2021 in Review

53 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2021, worth a combined $24.5M — down 50% from $49.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RDHL positions and 9 closed out — a net gain of 6 holders — while 15 added to existing stakes and 11 trimmed.

The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $522K. The largest seller was ARK Investment Management, cutting an estimated $5.21M.

  • 53 institutional investors held Redhill Biopharma (RDHL) as of Q3 2021, up from 48 in Q2 2021.
  • Funds reported $24.5M of Redhill Biopharma stock for Q3 2021, down 50% quarter-over-quarter.
  • 15 funds opened new Redhill Biopharma positions in Q3 2021 and 9 closed out, a net change of +6 holders.
  • The largest Redhill Biopharma buyer in Q3 2021 was Envestnet Asset Management, an estimated $522K added.
  • The largest Redhill Biopharma seller in Q3 2021 was ARK Investment Management, an estimated $5.21M sold.

Based on aggregated 13F filings for Q3 2021.